MAMU
RMD icon

Marathon Asset Management (UK)’s ResMed RMD Stock Holding History

Marathon Asset Management (UK)’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-289,346
Closed -$15.5M – 101
2015
Q4 		$15.5M Sell
289,346
-7,058
-2% -$398K 0.35% 72
2015
Q3 		$15.1M Buy
296,404
+384
+0.1% +$20.7K 0.36% 68
2015
Q2 		$16.7M Buy
296,020
+49,330
+20% +$3.11M 0.38% 64
2015
Q1 		$17.7M Sell
246,690
-2,912
-1% -$189K 0.43% 59
2014
Q4 		$14M Sell
249,602
-1,494
-0.6% -$78K 0.34% 62
2014
Q3 		$12.4M Buy
+251,096
New +$12.8M 0.3% 65

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marathon Asset Management (UK)'s RMD Position: Q1 2016 in Review

Marathon Asset Management (UK) sold out of ResMed (RMD) in Q1 2016, closing a stake of 289,346 shares — an estimated $15.5M sold.

Marathon Asset Management (UK) first reported a position in RMD in Q3 2014 and held it in 6 quarters. The position peaked at $17.7M in Q1 2015. 374 funds tracked by Wall St. Rank hold RMD as of Q1 2016.

  • Marathon Asset Management (UK) reported no remaining ResMed position as of Q1 2016 after selling out during the quarter.
  • Marathon Asset Management (UK) sold 289,346 ResMed shares in Q1 2016, an estimated $15.5M.
  • Marathon Asset Management (UK) first reported a position in ResMed in Q3 2014 and held it in 6 quarters.
  • Marathon Asset Management (UK)'s ResMed position peaked at $17.7M in Q1 2015.
  • 374 funds tracked by Wall St. Rank held ResMed as of Q1 2016.

Based on Marathon Asset Management (UK)'s 13F filing for Q1 2016, filed 20 Apr 2016.